http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107582566-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-132 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate | 2016-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107582566-B |
| titleOfInvention | Methods and compositions for modulating autoimmune diseases with polyamine compounds |
| abstract | The present invention provides methods and compositions for modulating autoimmune diseases with polyamine compounds. In particular, the invention provides macrophages and corresponding cell preparations treated with a polyamine compound, as well as compositions for up-regulating or down-regulating arginine levels in vivo. The preparation and the composition can be used for treating multiple sclerosis, and can inhibit inflammatory reaction by obviously reducing inflammatory cell infiltration and reducing the level of proinflammatory cytokines, thereby reducing the degree of inflammatory cell infiltration and demyelination of the central nervous system, reducing the incidence rate of multiple sclerosis and relieving the condition of illness. |
| priorityDate | 2016-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 950.